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With interest we read the article by Koster et al. about the anesthetic management in a 39 years old female with left ventricular hypertrabeculation/noncompaction (LVHT) scheduled for Cesarean section \[[@R001]\].

We have the following suggestions, comments and concerns.

The optimal anesthetic management of patients with LVHT is unknown as it may depend on the presence of additional cardiac abnormalities, underlying neuromuscular disorders (NMD), chromosomal abnormalities, or on the presence of pulmonary diseases.

It may also depend on the previous medical history, especially on systolic dysfunction, embolism, arrhythmias, or previous adverse reactions to anesthesia.

A family history positive for sudden cardiac death, heart failure, cardio-embolism, or adverse reactions to anesthetics could indicate that LVHT is familial and possibly associated with a NMD.

Since LVHT is frequently associated with myopathy, all patients should be investigated by a myologist before general anesthesia to prevent malignant hypertheremia, malignant hyperthermia-like reactions, worsening of myopathy, fatigue, or confusional state.

The following points are some that may be worth investigating: was there any indication other than LVHT, pulmonary hypertension or short stature for a NMD? Did the patient present with dysmorphic features or was the history positive for episodes of weakness or permanent weakness, wasting, easy fatigability or exercise intolerance? Did the patient report about double vision, muscle cramping, muscle aching, or was creatine-kinase elevated preoperatively?

The described patient obviously had pulmonary hypertension and dilative cardiomyopathy and it is essential to exclude those NMDs which display also pulmonary hypertension such as myotonic dystrophy \[[@R002]\], calpainopathy \[[@R003]\], dermatomyositis/polymyositis \[[@R004]\], caveolinopathy \[[@R005]\], mitochondrial disorder \[[@R006],[@R007]\], myasthenia gravis \[[@R008]\], arthrogryposis discared \[[@R009]\], or rigid spine syndrome \[[@R010]\].

Though LVHT is probably congenital in the majority of the cases, we do not agree that this is always the case as there are some patients in whom LVHT has developed post-natally (acquired LVHT) \[[@R011]\].

In these cases, LVHT may be hidden due to severe left ventricular hypertrophy, left ventricular dilatation or simply due to overlooking because of unawareness of the abnormality, ignorance, or reduced accuracy \[[@R012]\], or it may be also truly an acquired defect.

Overall, we strongly reccomend to investigate each patient with LVHT for NMD, particularly those scheduled for general anesthesia because patients with LVHT not only carry the risk of severe ventricular arrhythmias, but also of malignant hyperthermia or other adverse reactions to generalised anesthesia, typically observed in NMD patients.
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